The cornea is the outermost layer of the eye and is a vital component of focusing incoming light on the retina. Central corneal thickness (CCT) is now recognized to have a significant role in ocular health and is a risk factor for various ocular diseases, such as keratoconus and primary open angle glaucoma. Most previous genetic studies utilized European and Asian subjects to identify genetic loci associated with CCT. Minority populations, such as Latinos, may aid in identifying additional loci and improve our understanding of the genetic architecture of CCT. In this study, we conducted a genome-wide association study (GWAS) in Latinos, a traditionally understudied population in genetic research, to further identify loci contributing to CCT. Study participants were genotyped using either the Illumina OmniExpress BeadChip (~730K markers) or the Illumina Hispanic/SOL BeadChip (~2.5 million markers). All study participants were 40 years of age and older. We assessed the association between individual single nucleotide polymorphisms (SNPs) and CCT using linear regression, adjusting for age, gender, and principal components of genetic ancestry. To expand genomic coverage and to interrogate additional SNPs, we imputed SNPs from the 1000 Genomes Project reference panels. We identified a novel SNP, rs10453441 (P = 6.01E-09), in an intron of WNT7B that is associated with CCT. Furthermore, WNT7B is expressed in the human cornea. We also replicated 11 previously reported loci, including IBTK, RXRA-COL5A1, COL5A1, FOXO1, LRRK1, and ZNF469 (P < 1.25E-3). These findings provide further insight into the genetic architecture of CCT and illustrate that the use of minority groups in GWAS will help identify additional loci.
Introduction
The cornea is the clear, outermost layer of the eye that aids in refracting incoming light onto the lens, which is then further refocused onto the retina. Compared to the lens, the cornea has greater refractive power and thus, is a critical ocular structure to focus light on the retina. Due to the large refractive power, any structural variations of the cornea (i.e. smoothness, curvature, or thickness) may result in adverse effects on vision. Mounting evidence suggests central corneal thickness (CCT) plays a significant factor in ocular health. Thin CCT has been observed in several visual disorders, including brittle cornea syndrome, keratoconus, and osteogenesis imperfecta (1) (2) (3) . CCT is also an important endophenotype for primary open angle glaucoma (POAG). Most notably, thin CCT has been found to be associated with POAG in multiple epidemiologic studies (4) (5) (6) (7) (8) (9) (10) . Therefore, understanding the factors that influence CCT may help to better predict CCT and potentially, POAG.
Ethnic differences in CCT have been observed in several studies. Generally, Hispanics have slightly higher CCT measurements than Caucasians, while individuals of African descent exhibit the lowest CCT, and CCT from Asian populations representing a wide range of values (7, (11) (12) (13) . While environmental factors may contribute to the observed racial variation, genetic variants specific to certain ethnic populations are more likely to have a major role in CCT determination (14) . Moreover, CCT is a highly heritable trait, with heritability ranging from 0.60 to 0.95 (15, 16) . Taken together, these findings suggest that the primary factors determining CCT are genetic rather than environmental.
Recently, genome-wide association studies (GWAS) have identified numerous genetic loci that are associated with CCT in various ethnic populations. These GWAS, conducted in European, Asian, and Latino populations, have identified single nucleotide polymorphisms (SNPs) in or nearby AKAP13 (17, 18) , COL5A1 (18, 19) , COL8A2 (19) , FAM53B (20) , FOXO1 (20) , IBTK (17) , LRRK1 (17) , RXRA-COL5A1 (18, 19, 21, 22) , and ZNF469 (18) (19) (20) (21) to be associated with CCT. A meta-analysis consisting of a large number of European and Asian individuals identified 16 additional loci associated with CCT, including LPAR1 and ARID5B (23) . Furthermore, we reported the first GWAS on CCT in Latinos and replicated previously reported loci, as well as identified novel SNPs (22) .
While genetic loci associated with CCT have consistently been identified, these loci have primarily been found in populations of European and Asian descent. We hypothesize performing GWAS in minority populations may identify new loci associated with CCT, as well as elucidate the racial differences of CCT. Latinos, the largest minority group in the United States, are traditionally an understudied population among genetic studies. Furthermore, Latinos exhibit thicker CCT compared to other ethnic groups. Taken together, identifying novel genetic variants associated with CCT in Latinos may elucidate racial differences and further our understanding of the genetic architecture of CCT. Therefore, the purpose of this study is to conduct a larger GWAS using Latino subjects to identify novel genetic loci for CCT. To our knowledge, this is the largest GWAS for CCT conducted in a Latino population.
Results

Study Sample
The descriptive statistics of the study sample are presented in Table 1 . Overall, a total of 4,515 individuals were used to assess the associations between SNPs and CCT, of which 3,584 unrelated individuals were used as a discovery set and 931 related individuals were used in a replication set. The overall mean age (standard deviation) is 54.8 (10.5), with the discovery set and replication set having mean ages of 54.2 (9.9) and 56.9 (12.5), respectively. The proportion of females in the study sample is 58.8%, with the discovery set composed of 56.5% women and the replication set composed of 68.0% women. Combined, the CCT values are normally distributed with an overall mean of 550.0 (33.4) µm, with the average of the discovery and replicate sets as 550.4 (33.2) µm (range: 443-668) and 548.7 (34.0) µm (range: 451 -661), respectively.
Genome-Wide Association Results
The genomic control (GC) inflation factor, λ, was 1.05, after adjusting for age, gender, and principal components of genetic ancestry. A Q-Q plot was generated and is presented in Supplementary Figure 1 .
Upon visual inspection of the plot, the observed -log 10 (P values) do not deviate from the null, except at the extreme tail. This plot suggests proper control of population stratification in this Latino sample. Figure 1 presents a Manhattan plot displaying the discovery set SNP association P values for the 576, 798
SNPs included in this analysis. Table 2 summarizes the SNPs, rs3118515, rs12447690, and rs10453441, that reached genome-wide significance (P < 5 × 10 -8 ) during the discovery set analysis. Among these three SNPs, all have previously been associated with CCT except for rs10453441, which is a novel finding in this study. rs10453441 (P = 3.14 × 10 -8 , GRCh37/hg19 position 46,363,739, chromosome 22)
is located in an intron of the WNT7B gene (wingless-type MMTV integration site family, member 7B). For the replication set, we analyzed the top SNPs using a set of related individuals and adjusted for the relatedness among individuals using linear mixed-effects models. All three of the SNPs showed similar directionality of the effect estimates for the minor alleles, compared to the discovery set ( Table 2 ).
rs10453441 was significant (P = 0.03) in our replicate set. The meta-analysis of the discovery and replication sets strengthened the association for rs10453441, P = 6.01 × 10 -9 . Therefore, rs10453441
represents a novel genetic locus associated with CCT in Latinos. Furthermore, rs10453441 was associated with CCT in our Indian consanguineous pedigree dataset (240 individuals from 16 pedigrees, P = 5.85×10 -4 ) (24), providing another replication for the novel discovery. Similarly, the association result for SNP rs3118515 was also strengthened after the meta-analysis, P = 9.29 × 10 -11 .
Results From Imputed SNPs
To expand genomic coverage and further identify additional genetic loci associated with CCT, we used 
Analysis of Previously Reported Loci for CCT
We evaluated 52 previously reported SNPs that reached genome-wide significance (P < 5×10 -8 ) in
European and Asian populations to determine whether these associations were consistent in a Latino population. The results are summarized in (27) ; however, this later study was restricted to NEIGHBOR and GLAUGEN POAG cases and controls, suggesting that not all CCT loci are POAG related.
Biological Evidence
The WNT7B gene has been reported to be expressed in the human cornea (28) and the mouse cornea (29) .
WNT7B was upregulated in the human central cornea and is specific to the mature corneal epithelium (28) and was mainly expressed in the endothelial cell layer in the mouse cornea (29) . Genevestigator (see Web
Resources), an online database to verify gene expression in different tissue types, also shows that WNT7B
is highly expressed in normal human corneas (Supplementary Figure 2) . Table 4 summarizes the top five canonical pathways from IPA and KEGG pathways from WebGestalt through gene-set association testing of directly genotyped SNPs. The most significantly enriched canonical pathway is 14-3-3-mediated signaling (P = 2.9E-03), followed by the IGF-1 signaling (P = 2.9E-03), myc mediated apoptosis signaling (P = 6.45E-03), neuregulin signaling (P = 6.45E-03), and NGF signaling (P = 3.8E-02) pathways, respectively. The top pathway, 14-3-3-mediated signaling, is a family of proteins that are involved in cell cycle, apoptosis, and protein trafficking and the presence of 14-3-3 proteins have been reported in the human cornea (30). Similarly, the Myc mediated apoptosis signaling pathway is related to the cell cycle and may have a role in maintaining the homeostasis of the corneal epithelium. The IGF-1 signaling, neuregulin signaling, and NGF signaling pathways involve growth factors and IGF-1 (31), neuregulin 1 (32), and NGF (33) have been reported to have a biological effect in human corneas. In addition, the top KEGG pathways are metabolic pathways (P = 7.27E-06),
Pathway Analysis
ErbB signaling pathway (P = 2.95E-05), tight junction (P = 1.0E-04), pathways in cancer (P = 1.0E-04),
and T cell receptor signaling pathway (P = 8.0E-04). The ErbB family consists of receptor tyrosine kinases that regulates various biological responses, including cell proliferation, differentiation, migration, and carcinogenesis, and this family has been shown to play a role in corneal epithelial wound healing (34) . Tight junctions are composed of proteins that mediate cell adhesion and serve as diffusion barriers with the tight junction-related proteins occludin, claudin, and ZO-1 expressed in human corneal epithelium (35) . And lastly, genes that have been studied in tumor metastasis models were also found to be differentially expressed in the cornea (36) . Interestingly, during both wound healing and cancer development, related cells exhibit rapid proliferation and tissue remodeling (36) . Taken together, our pathway analysis results from IPA and KEGG yielded comparable pathways with regard to the cornea in that the programs identified pathways relevant to cellular proliferation, migration, and apoptosis, suggesting such pathways may have a role in the integrity and homeostasis of the human cornea.
Discussion
This study is the largest GWAS conducted in Latinos for CCT. We identified rs10453441 in the WNT7B gene on chromosome 22 as a novel SNP for CCT. Furthermore, one previously reported SNP on chromosome 9, rs3118515, and one previously reported SNP on chromosome 16 rs12447690 also reached genome-wide significance. These SNPs were replicated at the 0.05 significance level (one-sided P values being computed with regard to the direction of effect found in the discovery set) in our Latino replication set, except for rs12447690. The association of rs10453441 with CCT was also replicated in an Indian dataset (P = 5.85×10 -4 ) (24). We were also able to replicate 11 previous GWAS loci, such as variants in the RXRA-COL5A1, COL5A1, IBTK, FOXO1, LRRK1, and ZNF469 regions. Though genotype imputation using the 1KGP increased the number of SNPs in our dataset, we did not identify additional GWAS loci for CCT in the imputed dataset. As further support, the WNT7B gene is expressed in the human cornea, which provides biological evidence for its association with CCT.
The novel SNP identified here associated with CCT, rs10453441 is located in the genomic region that includes WNT7B, a member of the WNT gene family, a group of structurally related genes that encode secreted signaling proteins. This SNP has previously been positively associated with axial length and corneal curvature, ocular parameters related to myopia, in a GWAS among Asian and Caucasian populations (29) . These investigators further identified a positive association between this SNP and extreme myopia, as well as localized WNT7B expression in the endothelial cell layer of mouse cornea and the downregulation of this gene in extreme myopia. Compared to Miyake et al. (2014) , where rs10453441
was associated with an increase in both axial length and corneal curvature, our results identified its association with CCT. CCT is not highly correlated with either axial length or corneal curvature (37), suggesting rs10453441 may influence different ocular phenotypes in different ethnic groups.
As a member of Wnt signaling and one of 19 Wnt proteins, WNT7B was found to be upregulated in the central cornea of humans and the Wnt signaling pathway may have a role in primary limbal stem cell proliferation (28) . Similarly, various other components of Wnt signaling have previously been implicated in the cornea. Wnt4 has been detected in the basal and immediate parabasal limbal epithelial cells in both normal fetal and adult human corneas (38) . Additionally, during corneal wound healing, Wnt7a was found to promote the proliferation of corneal epithelial cells (39) . The results from our study suggest rs10453441 may play an important role in CCT determination, independent of axial length and corneal curvature, and similar to other members of Wnt signaling, WNT7B may have an active biological role in regulating CCT.
Our study has many strengths, including the use of the largest Latino dataset containing both ophthalmic and genotyped data thus far. We conducted a two stage GWAS, using both population-and family-based study designs to replicate associated loci. Our sample size was able to achieve 80% power to detect variants with MAF 0.455 explaining 1% (like rs10453441) of trait variation (two sided test, α p = 5×10 -8 , calculated by Quanto (40, 41) ). We imputed and analyzed SNPs from the 1KGP to extend genomic coverage to further identify common variants not directly genotyped, using a specialized imputation protocol for Latino populations (42) . Both the imputed and genotyped GWAS results are presented in the supplementary data. We also carried out imputation using our own Hispanic/SOL data as the reference panel and analyzed these SNPs using linear mixed models, though we did not identify any additional new loci for CCT (data not shown). Gene expression analysis provided biological support for the expression of the WNT7B gene in the cornea. This study, however, also has some limitations. Latinos are historically understudied in genetic research. Despite the largest Latino data for studying ophthalmic phenotypes, our sample size is limited compared to meta-analyses using European and Asian subjects. We emphasize the need to replicate our findings in an independent Latino cohort. Variants of smaller effects may also not be detected. The effect size estimates of GWAS hits may suffer from the winner's curse (43, 44) . For example, the bias-corrected beta for rs12447690 in the discovery set was -4.14 with a confidence interval [-2.06, -8.34] calculated using BR-squared software (45) via 1,000 bootstrap re-sampling. Due to the three-way admixture (the ancestral composition of this sample is shown in Supplementary Figure 3) , it is generally more challenging to impute in Latinos (42) . The imputation quality of the WNT7B region on chromosome 22 was low, which can mask other possible interesting SNPs, e.g. rs9330813 (P = 5.14×10 -8 ) and rs10453458 (P = 1.29×10 -8 ) only had imputation scores of Rsq = 0.74 and 0.56, respectively.
Chromosome 22 has previously been shown to be difficult to impute for Latinos (42) . As reference panels and imputation technologies continue to improve for Latinos, the ability to impute and consequently, identify associations with non-directly genotyped SNPs, may improve as well. We investigated association for the top SNP (rs10453441) in 5 independent European CCT studies, but did not observe consistent association with this SNP and CCT in these populations (Supplementary Table 1 ). This suggests that rs10453441 may not be generalized to the European populations. But it is also possible that the association in the European populations was mitigated by suboptimal imputation quality.
Furthermore, we are genotyping our entire cohort using the Illumina HumanExome BeadChip through MAGGS. As our genotyping progresses, we will have more power to uncover additional loci.
In summary, we identified a novel genome-wide significant association between rs10453441 in WNT7B
and CCT in the largest GWAS of CCT in Latinos. We also replicated previously reported SNPs identified in other ethnic groups. Furthermore, our pathway analysis identified relevant pathways associated with apoptosis and cell development for CCT. Our results suggest GWAS conducted in minority populations can identify additional loci associated with CCT not previously identified in GWAS or large-scale metaanalyses using European or Asian populations and may aid in furthering our understanding of ethnic differences of CCT, as well as elucidating the genetic architecture of CCT.
Materials and Methods
Ethics Statement
The following research was approved by the University of Illinois at Chicago, the University of Southern California Health Sciences Campus, and the Los Angeles Biomedical Research Institute at HarborUniversity of California, Los Angeles, (UCLA) institutional review boards. All clinical investigation was conducted according to the principles expressed in the Declaration of Helsinki.
Study Sample
We conducted this research using data collected from the Los Angeles Latino Eye Study (LALES), the largest population-based study of visual impairment and ophthalmic diseases conducted among 6,357
Latinos living in six census tracts in the city of La Puente, Los Angeles County, California. All subjects included in this study were 40 years of age and older and written, informed consent was obtained from each study participant.
Measurement of CCT
All study participants underwent a detailed ophthalmologic examination. Three CCT measurements were obtained in each eye using a commercial ultrasonic computation module (A-scan/pachymeter DGH 4000B SBH IOL Computation Module; DGH Tech, Inc., Exton, PA) during examination. The three CCT measurements were averaged to obtain a single value in each eye. The average CCT measurement for the left and right eyes was taken to yield the final CCT value. If CCT measurements were available for only one eye, this value was used as a surrogate for the final CCT measurement.
Genotyping and Quality Control
We genotyped a total of 4, Illumina, Inc.). Study participants whose genotyping call rate was less than 97% were excluded from further analysis. Additionally, study participants with gender inconsistency between reported and genetically inferred gender, missing CCT measurements, CCT outliers, and duplicates were removed.
After removal of these study subjects, 4,515 subjects remained for downstream analysis, of which 3,584 unrelated individuals were used as a discovery set (stage 1) and 931 first-degree relatives (416 families)
were used as a replication set (stage 2). The program PLINK (v1.90) was used to perform quality control on the genotype data (46) . SNPs that overlapped between the genotyping chips were retained for analysis and were further excluded if the minor allele frequency (MAF) < 1%, the call rate < 95%, or the HardyWeinberg equilibrium P values < 10 -6 . After the above quality control parameters, 576,798 SNPs remained for further analysis. SNPs were coded on the forward strand to facilitate the imputation process.
Genotype Imputation
To increase genomic coverage, we used Shapeit2 (47) We phased our genotypes using Shapeit2 and carried out genotype imputation using Minimac3 on the phased data. Genotypes that were imputed were coded as allelic dosages (estimated counts ranging from 0 to 2). Quality control parameters were applied to filter out low quality imputed SNPs, i.e. Rsq < 0.80 and MAF < 1%. After removal of low quality imputed SNPs, 6,844,888 imputed SNPs remained for further analysis.
Statistical Analysis
The program EIGENSOFT was used to infer principal components of genetic ancestry (48) . To make inferences of known ancestral populations, we included reference panels of unrelated Northern Europeans (CEU, n = 87) and West Africans (YRI, n = 88) from the 1000 Genomes Project (49) , and Native Americans (n = 105) (50) . The first four principal components were retained and were included as covariates during linear regression. The genomic control inflation factor (51) was calculated and applied and a quantile-quantile (Q-Q) plot was generated to visually inspect the distribution of test statistics. For the discovery set, we used PLINK to test the association between individual SNPs and CCT using linear regression, adjusting for age, gender, and principal components, assuming an additive genetic effects model (46) . For the replication set, the association between SNPs and CCT was assessed using a linear mixed-effects model (Proc Mixed procedure of SAS v9.4; SAS Institute, Cary, NC), adjusting for age, gender, and principal components of genetic ancestry. The compound symmetry covariance structure and the empirical "sandwich" estimator were used. Fixed-effects meta-analysis for the discovery and replication sets was conducted in METAL using inverse-variance weighting (52) . Accounting for genotype uncertainty, allelic dosages of imputed SNPs were analyzed using the software mach2qtl (see Web Resources). The conventional SNP P value significance threshold of 5 ×10 -8 was used to declare genome-wide significant SNPs. We applied the simpleM (25, 26, 53) method for multiple testing correction to evaluate previously reported loci. The software R (54) and LocusZoom (hg19 / 1KGP AMR) (55) were used for graphing.
Pathway Analysis
To investigate the contribution of combined genetic effects on the underlying biological processes influencing CCT, we performed gene-based and pathway analysis on the maximum number of unrelated individuals using SKAT-O (56), QIAGEN's Ingenuity Pathway Analysis (IPA) (see Web Resources), and WEB-based GEne SeT AnaLysis Toolkit (WebGestalt) (57) . Using all directly genotyped SNPs, we assigned these SNPs to genes according to genomic position based on the hg19 assembly. Moreover, in order to capture proximal regulatory and other functional elements occurring outside of a gene, we extended the gene boundaries to include SNPs ± 10kb of a gene. SNPs occurring in multiple gene boundaries were included in these boundaries separately. Similar to the GWAS model, the gene-set associations were further adjusted for age, gender, and principal components of genetic ancestry.
Enrichment of canonical pathways and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways
with genes associated with CCT was analyzed using IPA and WebGestalt. Canonical pathways and KEGG pathways with a P value < 0.05 after Benjamini-Hochberg multiple testing adjustment (58) were declared significantly enriched. The top five most enriched canonical pathways from IPA and KEGG pathways from WebGestalt are reported.
Web Resources
The URLs for downloaded data and programs: The most significant SNP, using the maximum number of unrelated individuals, is plotted in purple. The lead SNP, rs10453441 (P = 7.15 × 10 -9 ), remained the most significantly associated in the WNT7B gene. For the 576, 798 SNPs that passed quality control filters in the discovery set, -log 10 (P values) is plotted against the corresponding expected -log 10 (P values). The genomic control inflation factor λ = 1.05.
Supplementary Figure 2. Expression of WNT7B in various tissues from Genevestigator
The boxplot-list displays the WNT7B gene expression in 62 postmortem healthy human anatomical parts, ranked by the level of expression. WNT7B is highly expressed in the human cornea (n = 6).
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